新基制药(CELG)

108.24 0.00 0.0%

今开:0.0昨收:108.24
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:7.7035975315E10

新基制药的最新讨论

壹手黄金2019-01-04 09:56

【早餐|1月4日】
苹果业绩爆雷、美制造业数据拖累,美股大跌,纳指跌3%,苹果跌约10%,伯克希尔创七年来第二大跌幅;布油涨近2%;两年期美债收益率跌10个基点。
美12月ISM制造业创金融危机后最大降幅;12月ADP新增就业27.1万人远超预期,创近两年新高。
特朗普经济顾问警告称苹果只是...查看全文

富贵的加薪小灵巧2019-01-04 00:19

$中国生物制药(01177)$ $新基制药(CELG)$ 行業溢價被收購是好事 併購又要開始了查看全文

北二院精神科王主任2019-01-03 23:41

精准的错误(ZH1409330) @神圣剑帝 $苹果(AAPL)$ AMD(AMD) 美国航空(AAL) $英伟达(NVDA)$ 纳斯达克的千斤坠啊 我以特朗普知名命令你 干掉 $新基制药(CELG)$查看全文

金融投资12019-01-03 23:10

$新基制药(CELG)$ 23:05
都亏了11%的嘴炮王子@Stevevai1983 。这种新兵蛋子趁行情好赚了点钱就发私募。呵呵牛逼查看全文

一只熊2019-01-03 22:27

$新基制药(CELG)$ 740亿美元——恒瑞医药1000多亿,也难说就很贵了。查看全文

刹那12432019-01-03 22:25

$新基制药(CELG)$ 居然被卖了[吐血]查看全文

璟悦Jingyue2019-01-03 21:44

哇,可惜啊。差点就买了celg。查看全文

群氓鄙陋2019-01-03 21:33

$新基制药(CELG)$ 740亿美金被收购,现在500亿美金市值不到,可以买吗查看全文

梨园牛倌2019-01-03 21:17

$新基制药(CELG)$ 新基都能被收购,感慨世事无常。查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70

新基制药的公告

$新基制药(CELG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013792  Size: 69 KB 网页链接

$新基制药(CELG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013796  Size: 42 KB 网页链接

$新基制药(CELG)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001140361-19-022527  Act: 34  Size: 15 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022225  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022228  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022200  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022201  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022206  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022210  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022217  Act: 33  Size: 39 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74